Therapeutic drug monitoring to guide clinical decision-making in IBD patients with loss of response to anti-TNF: A Delphi technique-based consensus

被引：0
|
作者：
Greuter, Thomas [1 ]
Maillard, Michel [2 ]
Juillerat, Pascal [3 ]
Michetti, Pierre [4 ]
Seibold, Frank [5 ]
Mottet, Christian [6 ]
Sauter, Bernhard [7 ]
Rogler, Gerhard [1 ]
Vavricka, Stephan R. [1 ,8 ]
机构：
[1] Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland
[2] CHU Vaudois, Univ Lausanne Hosp, Div Gastroenterol & Hepatol, Lausanne, Switzerland
[3] Univ Hosp Bern, Inselspital, Clin Visceral Surg & Med, Gastroenterol, Bern, Switzerland
[4] Clin La Source Beaulieu, Crohn & Colitis Ctr, Lausanne, Switzerland
[5] Hochhaus Lindenhofspital, Crohn Colitis Zentrum, Bern, Switzerland
[6] Hop Neuchatelois Pourt, Div Gastroenterol, Neuchatel, Switzerland
[7] Hirslanden Private Clin Grp, Gastrozentrum Hirslanden, Zurich, Switzerland
[8] Zentrum Gastroenterol & Hepatol, Zurich, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2018年 / 148卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
G32
引用
收藏
页码：20S / 20S
页数：1
相关论文
共 15 条
  • [1] Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based Consensus
    Greuter, Thomas
    Maillard, Michel H.
    Juillerat, Pascal
    Michetti, Pierre
    Seibold, Frank
    Mottet, Christian
    Zahnd, Nadine
    Sauter, Bernhard
    Schoepfer, Alain M.
    Rogler, Gerhard
    Vavricka, Stephan R.
    [J]. DIGESTION, 2020, 101 (06) : 683 - 691
  • [2] Is anti-TNF therapeutic drug monitoring of value in IBD patients in clinical remission?
    Subramaniam, K.
    Watthayalage, R.
    Neeman, T.
    Pavli, P.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 149 - 149
  • [3] Is anti-TNF therapeutic drug monitoring of value in IBD patients in clinical remission?
    Subramaniam, K.
    Watthayalage, R.
    Neeman, T.
    Pavli, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S353 - S353
  • [4] Clinical value of routine therapeutic anti-TNF drug monitoring (TDM) in Inflammatory Bowel Disease (IBD) patients in clinical practice
    Guirgis, M.
    Bianchetti, D.
    Dorta, G.
    Michetti, P.
    Maillard, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S235 - S236
  • [5] Clinical response to a second or third anti-TNF agent after discontinuation of the first. Implications for therapeutic decision-making
    Haraoui, Boulos
    Cameron, Louise
    Sauvageau, Diane
    Ouellet, Michele
    Choquette, Denis
    Raynauld, Jean-Pierre
    [J]. JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) : 1618 - 1619
  • [6] q Secondary loss of response to anti-TNF in inflammatory bowel diseases. Therapeutic drug monitoring. Utility in clinical practice
    Jimenez, M.
    Sierra-Ausin, M.
    Cano, N.
    Suarez, P.
    Fernandez-Gundin, M.
    Saez-Villafane, M.
    Monteserin, L.
    Molina, G.
    Reyes, N.
    Viso, D.
    Jorquera, F.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S298 - S298
  • [7] Clinical Impact of Routine Anti-Tumour Necrosis Factor (Anti-TNF) Therapeutic Drug Monitoring (TDM) in Management of Inflammatory Bowel Disease (IBD) Patients
    Guirgis, Marianne
    Bianchetti, Davide
    Dorta, Gian O.
    Michetti, Pierre F.
    Maillard, Michel H.
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S857 - S858
  • [8] Clinical impact of routine anti-Tumour Necrosis Factor (anti-TNF) therapeutic drug monitoring (TDM) in the management of Inflammatory Bowel Disease (IBD) patients
    Guirgis, M.
    Bianchetti, D.
    Dorta, G.
    Michetti, P.
    Maillard, M.
    [J]. SWISS MEDICAL WEEKLY, 2015, 145 : S3 - S3
  • [9] Interest in the addition of azathioprine (AZA) to the switch of anti-TNF in IBD patients in loss of response with undetectable anti-TNF trough levels and anti-drug antibodies: A prospective randomised trial
    Roblin, X.
    Paul, S.
    Boschetti, G.
    Phelip, J. M.
    Del Tedesco, E.
    Berger, A.
    Nancey, S.
    Williet, N.
    Flourie, B.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S414 - S415
  • [10] Anti-infliximab antibody concentrations guide therapeutic decision-making in patients with Crohn's disease losing clinical response
    Dreesen, E.
    Van Stappen, T.
    Ballet, V.
    Tops, S.
    Compernolle, G.
    Van Assche, G.
    Ferrante, M.
    Vermeire, S.
    Gils, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S405 - S406
12